Quarterly Results Results Snapshot
YoYQoQ
Figures in Rs cr
Consolidate Quarterly Results
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Jun'23
Net Sales
45.14
44.74
43.05
47.32
46.50
43.54
41.94
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
45.14
44.74
43.05
47.32
46.50
43.54
41.94
Raw Material Cost
28.52
28.94
21.67
21.82
29.10
27.67
26.11
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-6.20
-4.50
2.43
1.77
-4.11
-4.52
-5.24
Employee Cost
8.00
7.63
7.84
8.39
8.01
7.10
6.56
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
-0.01
0.01
-0.01
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
8.12
7.36
7.67
9.58
8.62
8.65
7.56
Total Expenditure (Excl Depreciation)
38.44
39.43
39.60
41.57
41.61
38.90
34.99
Operating Profit (PBDIT) excl Other Income
6.70
5.31
3.45
5.75
4.89
4.64
6.95
Other Income
0.14
0.29
0.59
0.57
0.83
0.55
0.38
Operating Profit (PBDIT)
6.84
5.60
4.04
6.32
5.72
5.19
7.33
Interest
0.76
1.04
0.71
1.89
0.65
0.91
0.96
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
6.08
4.56
3.33
4.43
5.07
4.28
6.37
Depreciation
2.21
2.61
1.77
1.77
1.80
1.82
1.69
Profit Before Tax
3.88
1.96
1.56
2.66
3.27
2.46
4.68
Tax
0.95
1.05
0.76
0.62
1.24
0.99
0.74
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2.92
0.90
0.80
2.04
2.03
1.48
3.95
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2.92
0.90
0.80
2.04
2.03
1.48
3.95
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.55
-0.55
-0.55
-0.09
-0.37
-0.04
-0.23
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3.47
1.46
1.35
2.13
2.40
1.51
4.18
Equity Capital
12.71
12.71
12.71
12.71
12.65
12.65
12.65
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
2.73
1.15
1.06
1.68
1.9
1.19
3.3
Diluted Earnings per share
2.3
0.71
0.63
1.61
1.6
1.17
3.12
Operating Profit Margin (Excl OI)
14.84%
11.87%
8.01%
12.15%
10.52%
10.66%
16.57%
Gross Profit Margin
13.47%
10.19%
7.74%
9.36%
10.9%
9.83%
15.19%
PAT Margin
6.47%
2.01%
1.86%
4.31%
4.37%
3.4%
9.42%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2024 is -2.92% vs 30.69% in Dec 2023
Consolidate Net Profit
YoY Growth in quarter ended Dec 2024 is 44.58% vs -36.17% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2024 is 37.01% vs -16.70% in Dec 2023
Interest
YoY Growth in quarter ended Dec 2024 is 16.92% vs -4.41% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2024 has improved from Dec 2023
Compare Quarterly Results Of Medicamen Biotec With
Figures in Rs cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
45.14
3,230.00
-3,184.86
-98.60%
Other Operating Income
0.00
0.00
0.00
Total Operating income
45.14
3,230.00
-3,184.86
-98.60%
Raw Material Cost
28.52
536.11
-507.59
-94.68%
Purchase of Finished goods
0.00
387.30
-387.30
-100.00%
(Increase) / Decrease In Stocks
-6.20
11.81
-18.01
-152.50%
Employee Cost
8.00
709.71
-701.71
-98.87%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
8.12
755.27
-747.15
-98.92%
Total Expenditure (Excl Depreciation)
38.44
2,400.20
-2,361.76
-98.40%
Operating Profit (PBDIT) excl Other Income
6.70
829.80
-823.10
-99.19%
Other Income
0.14
77.32
-77.18
-99.82%
Operating Profit (PBDIT)
6.84
907.12
-900.28
-99.25%
Interest
0.76
220.93
-220.17
-99.66%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
6.08
686.19
-680.11
-99.11%
Depreciation
2.21
192.30
-190.09
-98.85%
Profit Before Tax
3.88
497.33
-493.45
-99.22%
Tax
0.95
112.81
-111.86
-99.16%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
2.92
381.08
-378.16
-99.23%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
2.92
381.08
-378.16
-99.23%
Share in Profit of Associates
0.00
3.44
-3.44
-100.00%
Minority Interest
-0.55
4.29
-4.84
-112.82%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3.47
380.23
-376.76
-99.09%
Equity Capital
12.71
40.06
-27.35
-68.27%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
2.73
9.49
-6.76
-71.23%
Diluted Earnings per share
2.30
9.44
-7.14
-75.64%
Operating Profit Margin (Excl OI)
14.84%
25.69%
0.00
-10.85%
Gross Profit Margin
13.47%
21.24%
0.00
-7.77%
PAT Margin
6.47%
11.90%
0.00
-5.43%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 45.14 Cr
in Dec 2024Figures in Rs Cr
QoQ Growth in quarter ended Dec 2024 is 0.89% vs 3.93% in Sep 2024
YoY Growth in quarter ended Dec 2024 is -2.92% vs 30.69% in Dec 2023
Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.47 Cr
in Dec 2024Figures in Rs Cr
QoQ Growth in quarter ended Dec 2024 is 137.67% vs 8.15% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 44.58% vs -36.17% in Dec 2023
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.70 Cr
in Dec 2024Figures in Rs Cr
QoQ Growth in quarter ended Dec 2024 is 26.18% vs 53.91% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 37.01% vs -16.70% in Dec 2023
Quarterly - Interest
Interest 0.76 Cr
in Dec 2024Figures in Rs Cr
QoQ Growth in quarter ended Dec 2024 is -26.92% vs 46.48% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 16.92% vs -4.41% in Dec 2023
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.84%
in Dec 2024Figures in Rs %
QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024
YoY Growth in quarter ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
